Lewandowski E, Zhang X, Tan H, Jaskolka-Brown A, Kohaal N, Frazier A
Nat Commun. 2025; 16(1):1266.
PMID: 39893201
PMC: 11787374.
DOI: 10.1038/s41467-025-56651-x.
Hu B, Han Y, Zhang W, Zhang Q, Gu W, Bi J
BMC Med Res Methodol. 2024; 24(1):323.
PMID: 39736527
PMC: 11686916.
DOI: 10.1186/s12874-024-02433-w.
Yang Q, Yue C, Chen M, Ling Y, Dong Q, Zhou Y
Sci Rep. 2024; 14(1):30682.
PMID: 39730426
PMC: 11680907.
DOI: 10.1038/s41598-024-79734-z.
Valderrama-Beltran S, Cuervo-Rojas J, Rondon M, Montealegre-Diaz J, Vera J, Martinez-Vernaza S
PLoS One. 2024; 19(12):e0316207.
PMID: 39724211
PMC: 11670996.
DOI: 10.1371/journal.pone.0316207.
Yang M, Kim M, Zhan P
Acta Pharm Sin B. 2024; 14(9):4189-4192.
PMID: 39309490
PMC: 11413657.
DOI: 10.1016/j.apsb.2024.07.001.
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.
Paciello I, Pierleoni G, Pantano E, Antonelli G, Pileri P, Maccari G
Cell Rep. 2024; 43(9):114645.
PMID: 39207904
PMC: 11422482.
DOI: 10.1016/j.celrep.2024.114645.
Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.
Mostafa H, Fall A, Norton J, Sachithanandham J, Yunker M, Abdullah O
Microbiol Spectr. 2024; 12(10):e0111624.
PMID: 39162510
PMC: 11448398.
DOI: 10.1128/spectrum.01116-24.
Emergence of COVID-19's JN.1 Subvariant Sparks Outbreak in India.
Diksha , Kamal R, John O, Narang R, Singh A
Infect Disord Drug Targets. 2024; 25(2):e100724231823.
PMID: 38988174
DOI: 10.2174/0118715265313527240705063308.
Comparison of COVID-19 Hospitalization and Death Between Solid Organ Transplant Recipients and the General Population in Canada, 2020-2022.
Naylor K, Knoll G, Treleaven D, Kang Y, Garg A, Stirling K
Transplant Direct. 2024; 10(7):e1670.
PMID: 38953040
PMC: 11216672.
DOI: 10.1097/TXD.0000000000001670.
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
de Prost N, Audureau E, Guillon A, Handala L, Preau S, Guigon A
Ann Intensive Care. 2024; 14(1):101.
PMID: 38940865
PMC: 11213836.
DOI: 10.1186/s13613-024-01319-w.
Coding-complete genomes of 18 SARS-CoV-2 Omicron JN.1, JN.1.4, and JN.1.11 sub-lineages in Bangladesh.
Tahsin A, Hasan M, Rahman S, Jubair M, Afrad M, Khan M
Microbiol Resour Announc. 2024; 13(6):e0013524.
PMID: 38656213
PMC: 11237443.
DOI: 10.1128/mra.00135-24.
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X.
Hu B, Guo H, Si H, Shi Z
Front Med. 2024; 18(1):1-18.
PMID: 38561562
DOI: 10.1007/s11684-024-1066-6.
Current clinical findings of acute neurological syndromes after SARS-CoV-2 infection.
Wang M, Wang J, Ren Y, Lu L, Xiong W, Li L
MedComm (2020). 2024; 5(3):e508.
PMID: 38463395
PMC: 10924641.
DOI: 10.1002/mco2.508.
Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise.
Parums D
Med Sci Monit. 2024; 30:e943911.
PMID: 38298093
PMC: 10845785.
DOI: 10.12659/MSM.943911.
